Back

Spared cognitive and social function following perinatal ablation of ATRX despite transient microglia dysregulation

Mansour, K. Y.; Shafiq, S.; Berube, N. G.

2025-08-06 animal behavior and cognition
10.1101/2025.08.06.668920 bioRxiv
Show abstract

Mutations in the chromatin-remodelling factor ATRX underlie syndromic ID and ASD, yet the contribution of microglial ATRX to early brain development remains unknown. We used a tamoxifen-inducible Cx3cr1-CreERT2 system to delete Atrx in microglia during the first postnatal week, achieving >90% recombination at one month of age. At both one and three months, ATRX-null microglia displayed a sustained increase in CD68-positive phagocytic foci and in Ki67+ proliferative microglia, but an unexpected [~]20% reduction in microglial density, despite only modest evidence of caspase-3-mediated apoptosis. A comprehensive behavioural battery conducted between three and six months revealed normal anxiety, locomotion, learning, memory, social interaction and sensory gating, coinciding with a decline in knockout efficiency to [~]45% in cortex and [~]75% in hippocampus, suggestive of microglial repopulation by ATRX-expressing cells. These findings demonstrate that perinatal loss of ATRX drives chronic microglial reactivity and turnover with no discernable effects on neurobehaviours, suggesting a developmental resilience of neural circuits to transient microglial dysregulation.

Published in Scientific Reports (predicted rank #7) · training set

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.